🤖 Generated with AI assistance · Does not replace individualized medical advice.
Interpretable AI Model Predicts pCR in Breast Cancer Using Contrast-Enhanced Ultrasound
Why it matters
The article describes a machine learning model that integrates standard pre-treatment variables—analytical markers, receptor status, Ki-67, and contrast-enhanced ultrasound features—to forecast which patients will achieve pathological complete response (pCR) after neoadjuvant treatment. The model achieved an AUC of 0.83, demonstrating promising predictive accuracy. Importantly, the CatBoost algorithm provides interpretability, allowing clinicians to understand which features drive the prediction. This could help tailor treatment strategies early, potentially sparing patients from ineffective therapies. However, the authors emphasize that external validation is still needed before clinical implementation.
Consider integrating contrast-enhanced ultrasound with routine biomarkers to identify breast cancer patients likely to achieve pCR, pending external validation of this interpretable AI model.
Read the full article: ¿Quién alcanzará la pCR? Un modelo de IA interpretable con ecografía con contraste para predecir la respuesta al tratamiento neoadyuvante en cáncer de mama
Originally published on ppj.es by Dr. Javier Pumares.